EDNRB (Endothelin receptor type B) variants and mutations
EDNRB (also known as Endothelin receptor type B) is a human protein-coding gene encoding an endothelin receptor type B protein. Its annotated function is non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. It is annotated at the cell membrane. This analysis covers 857 EDNRB variants and mutations. Of these, 69% have computational variant effect predictions. Disease context includes Waardenburg syndrome type 4A, Waardenburg-Shah syndrome, and ABCD syndrome. Example EDNRB variants include Q2H, Q2L, and Q2R.
Variant analysis overview
- Gene: EDNRB
- Protein: Endothelin receptor type B
- UniProt accession: P24530
- Organism: Homo sapiens
- Variants analyzed: 857
- Variant scope: all variants
- Completed: 2026-08-27
Variant and mutation evidence
- Variant composition: 638 unspecified-consequence records; 1 stop retained variant; 1 in-frame deletions; 2 stop lost; 123 missense variants; 71 synonymous variants; 15 frameshift variants; 9 stop-gained variants
- Prediction scores: 594 variants have prediction scores (69% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Waardenburg syndrome type 4A, Waardenburg-Shah syndrome, ABCD syndrome, pulmonary arterial hypertension, pulmonary hypertension, hypertensive disorder, systemic sclerosis, Hirschsprung disease, Waardenburg syndrome, Abnormality of the skeletal system, congenital heart disease, hair color.
Protein structure and variant hotspots
- Protein features: 7 transmembrane segments; 7 post-translational modification sites.
- Structural context: 298 variants have structural context.
- PTM context: 17 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable EDNRB variants
Examples include Q2H, Q2L, Q2R, P3L, P4A, P4H, P5T, S6G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- Q2H (p.Gln2His), gnomAD rs1406054889
- Q2L (p.Gln2Leu), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57526, Variant assessed as somatic; moderate impact.
- Q2R (p.Gln2Arg), gnomAD rs1468720481, CADD 18.90, PolyPhen-2 0.00
- P3L (p.Pro3Leu), rs200047993, ClinGen CA7012414, ClinVar RCV003197311, ExAC rs200047993, CADD 12.50, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases
- P4A (p.Pro4Ala), ExAC rs777992864, gnomAD rs777992864, CADD 9.46, PolyPhen-2 0.00
- P4H (p.Pro4His), cosmic curated COSV10522
- P5T (p.Pro5Thr), rs12720160, ClinGen CA7012412, ClinVar RCV002606197, UniProt VAR 019285, CADD 10.40, PolyPhen-2 0.00, Uncertain significance, not provided
- S6G (p.Ser6Gly), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, CADD 16.70, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- L7M (p.Leu7Met), rs1239813325, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57522, gnomAD rs1239813325, CADD 23.60, Variant assessed as somatic; moderate impact.
- L7Q (p.Leu7Gln), rs5345, UniProt VAR 014675, Ensembl rs5345, AlphaMissense 0.09, MetaLR 0.08
- L7R (p.Leu7Arg), cosmic curated COSV10644
- C8G (p.Cys8Gly), ExAC rs765870134, TOPMed rs765870134, gnomAD rs765870134, CADD 6.07, PolyPhen-2 0.05
- G9E (p.Gly9Glu), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, Variant assessed as somatic; moderate impact.
- G9R (p.Gly9Arg), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, Ensembl rs914618888, CADD 9.32, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- G9V (p.Gly9Val), TOPMed rs1879939500, CADD 16.30, PolyPhen-2 0.13
- R10C (p.Arg10Cys), rs1204381719, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57522, gnomAD rs1204381719, CADD 14.70, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- R10H (p.Arg10His), NCI-TCGA Cosmic COSV5751, cosmic curated COSV57519, NCI-TCGA Cosmic COSV5752, CADD 15.80, PolyPhen-2 0.00, Likely benign, Waardenburg syndrome type 4A
- R10L (p.Arg10Leu), NCI-TCGA Cosmic COSV5751, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57524, CADD 15.30, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- A11S (p.Ala11Ser), TOPMed rs1879938838, CADD 22.80, PolyPhen-2 0.16
- A11T (p.Ala11Thr), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57521, CADD 19.80, PolyPhen-2 0.05, Variant assessed as somatic; moderate impact.
- A11V (p.Ala11Val), ExAC rs754162462, TOPMed rs754162462, gnomAD rs754162462, CADD 19.80, PolyPhen-2 0.00
- L12V (p.Leu12Val), Ensembl rs199558735
- V13D (p.Val13Asp), Ensembl rs2137640356, CADD 24.00, PolyPhen-2 0.58
- V13F (p.Val13Phe), cosmic curated COSV10052, CADD 19.80, PolyPhen-2 0.19
- V13G (p.Val13Gly), NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57528, Variant assessed as somatic; moderate impact.
- A14G (p.Ala14Gly), 1000Genomes rs548023225, TOPMed rs548023225, CADD 24.90, PolyPhen-2 0.28, Uncertain significance, not provided
- A14V (p.Ala14Val), rs548023225, NCI-TCGA Cosmic COSV5751, cosmic curated COSV57519, 1000Genomes rs548023225, CADD 24.80, PolyPhen-2 0.32, Uncertain significance, Waardenburg syndrome type 4A
- L15V (p.Leu15Val), Ensembl rs2137640336
- V16F (p.Val16Phe), rs142767792, ClinGen CA7012406, ClinVar RCV003198956, 1000Genomes rs142767792, CADD 16.10, PolyPhen-2 0.08, Uncertain significance, Inborn genetic diseases
- V16L (p.Val16Leu), 1000Genomes rs142767792, ExAC rs142767792, TOPMed rs142767792, gnomAD rs142767792, CADD 6.67, PolyPhen-2 0.00, Uncertain significance
- L17F (p.Leu17Phe), rs5346, ClinGen CA7012405, ClinVar RCV000221012, ClinVar RCV000297140, CADD 13.60, PolyPhen-2 0.00, Conflicting interpretations, not specified; Hirschsprung disease, susceptibility to, 2; not provided
- L17P (p.Leu17Pro), UniProt VAR 078312, Pathogenic, found in patients with Waardenburg syndrome 2
- C19* (p.Cys19Ter), rs768126403, ClinGen CA388453132, ClinVar RCV000721946, ExAC rs768126403, CADD 32.00, Pathogenic
- C19S (p.Cys19Ser), rs2501611059, ClinGen CA388453134, ClinVar RCV003877591, Uncertain significance, not provided
- G20D (p.Gly20Asp), cosmic curated COSV10052, CADD 17.40, PolyPhen-2 0.05
- G20S (p.Gly20Ser), rs762469442, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57525, ExAC rs762469442, CADD 12.20, PolyPhen-2 0.00, Uncertain significance, not provided
- S22* (p.Ser22Ter), TOPMed rs1879936405, CADD 33.00
- S22A (p.Ser22Ala), gnomAD rs1382140942, CADD 3.97, PolyPhen-2 0.00
- R23P (p.Arg23Pro), TOPMed rs1879935970, gnomAD rs1879935970, CADD 9.72
- R23Q (p.Arg23Gln), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, Variant assessed as somatic; moderate impact.
- R23W (p.Arg23Trp), rs769618877, ClinGen CA7012401, cosmic curated COSV10463, ClinVar RCV002025575, CADD 19.80, PolyPhen-2 0.13, Uncertain significance, not provided
- I24S (p.Ile24Ser), cosmic curated COSV10522
- W25G (p.Trp25Gly), Ensembl rs1594373845
- G26R (p.Gly26Arg), rs1235599209, ClinGen CA388453094, ClinVar RCV001758372, gnomAD rs1235599209, CADD 22.70, Uncertain significance, not provided
- E27D (p.Glu27Asp), TOPMed rs1879935108
- E28K (p.Glu28Lys), rs1879934925, ClinGen CA388453080, ClinVar RCV002735145, NCI-TCGA TCGA novel, CADD 19.90, PolyPhen-2 0.00, Uncertain significance, not provided
- E28Q (p.Glu28Gln), Ensembl rs1879934925, CADD 22.10, PolyPhen-2 0.00
- R29K (p.Arg29Lys), NCI-TCGA Cosmic COSV5751, cosmic curated COSV57519, Variant assessed as somatic; moderate impact.
- R29T (p.Arg29Thr), Ensembl rs1297137815
- G30D (p.Gly30Asp), cosmic curated COSV57522, 1000Genomes rs551739242, ExAC rs551739242, TOPMed rs551739242, CADD 12.70, PolyPhen-2 0.01
- F31C (p.Phe31Cys), Ensembl rs1879934254
- P32L (p.Pro32Leu), cosmic curated COSV57527, TOPMed rs1879933607, CADD 16.10, PolyPhen-2 0.00, Uncertain significance, not provided
- P32Q (p.Pro32Gln), cosmic curated COSV10589
- P32S (p.Pro32Ser), rs200723251, ClinGen CA7012398, ClinVar RCV003719771, ClinVar RCV005325788, CADD 8.44, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases; not provided
- P33L (p.Pro33Leu), cosmic curated COSV57522, CADD 20.40
- P33S (p.Pro33Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, CADD 12.50, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- D34E (p.Asp34Glu), rs149740482, ClinGen CA7012395, ClinVar RCV002582236, ClinVar RCV002602540, CADD 0.12, PolyPhen-2 0.01, Uncertain significance, Inborn genetic diseases; not provided
- D34G (p.Asp34Gly), cosmic curated COSV10609, CADD 12.60, PolyPhen-2 0.00
- D34H (p.Asp34His), cosmic curated COSV57520
- R35T (p.Arg35Thr), rs1259767883, ClinGen CA388453031, ClinVar RCV001937031, gnomAD rs1259767883, CADD 7.36, PolyPhen-2 0.01, Uncertain significance, not provided
- A36D (p.Ala36Asp), ExAC rs752856831, gnomAD rs752856831, CADD 21.50, PolyPhen-2 0.00
- A36S (p.Ala36Ser), gnomAD rs1354646550, CADD 8.87, PolyPhen-2 0.02
- A36V (p.Ala36Val), cosmic curated COSV10887
- T37I (p.Thr37Ile), gnomAD rs1288505904, CADD 23.30, PolyPhen-2 0.06
- P38L (p.Pro38Leu), rs779495524, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, ExAC rs779495524, CADD 11.10, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- L39F (p.Leu39Phe), Ensembl rs777101295
- L40S (p.Leu40Ser), cosmic curated COSV57525
- Q41E (p.Gln41Glu), Ensembl rs1879931464
- A43S (p.Ala43Ser), gnomAD rs200304077, CADD 6.81, PolyPhen-2 0.00, Uncertain significance, not provided
- A43T (p.Ala43Thr), gnomAD rs200304077, CADD 12.70, PolyPhen-2 0.01
- E44* (p.Glu44Ter), cosmic curated COSV10052
- E44D (p.Glu44Asp), TOPMed rs1401360436, gnomAD rs1401360436, CADD 15.70, PolyPhen-2 0.04
- E44K (p.Glu44Lys), NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV5751, cosmic curated COSV57519, Variant assessed as somatic; moderate impact.
- E44Q (p.Glu44Gln), TOPMed rs1879931000
- E44V (p.Glu44Val), ExAC rs755457512, CADD 22.70, PolyPhen-2 0.02
- I45T (p.Ile45Thr), TOPMed rs990292887
- T47K (p.Thr47Lys), gnomAD rs1316261633, CADD 23.20, PolyPhen-2 0.03
- T47M (p.Thr47Met), cosmic curated COSV57519, CADD 24.80, PolyPhen-2 0.15
- P48L (p.Pro48Leu), 1000Genomes rs538237989, TOPMed rs538237989, gnomAD rs538237989, CADD 20.90, PolyPhen-2 0.00, Uncertain significance, not provided
- T50N (p.Thr50Asn), cosmic curated COSV57526
- K51E (p.Lys51Glu), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57522, Ensembl rs1594373723, Variant assessed as somatic; moderate impact.
- K51N (p.Lys51Asn), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57525, CADD 16.10, PolyPhen-2 0.01, Variant assessed as somatic; moderate impact.
- T52A (p.Thr52Ala), cosmic curated COSV10052
- T52I (p.Thr52Ile), rs139997339, ClinGen CA253049872, ClinVar RCV002774840, ESP rs139997339, CADD 11.90, PolyPhen-2 0.00, Uncertain significance, not provided
- L53S (p.Leu53Ser), ExAC rs766651046, gnomAD rs766651046, CADD 14.00, PolyPhen-2 0.00
- W54* (p.Trp54Ter), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57524, Variant assessed as somatic; high impact.
- W54C (p.Trp54Cys), Ensembl rs1879928418, CADD 23.00, PolyPhen-2 0.43
- W54R (p.Trp54Arg), cosmic curated COSV57528, gnomAD rs1362059171, CADD 8.20, PolyPhen-2 0.00
- P55R (p.Pro55Arg), ExAC rs751161032, gnomAD rs751161032, CADD 19.80, PolyPhen-2 0.02
- K56T (p.Lys56Thr), rs763764641, ClinGen CA7012387, ClinVar RCV003062604, ExAC rs763764641, CADD 0.37, PolyPhen-2 0.00, Uncertain significance, not provided
- G57D (p.Gly57Asp), cosmic curated COSV10522, CADD 8.99, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases
- G57S (p.Gly57Ser), rs1801710, ClinGen CA257561, cosmic curated COSV10052, ClinVar RCV000018117, CADD 7.27, PolyPhen-2 0.01, Conflicting interpretations, not specified; not provided; Hirschsprung disease, susceptibility to, 2
- G57V (p.Gly57Val), cosmic curated COSV10739, gnomAD rs1879927173, CADD 14.50
- S58F (p.Ser58Phe), gnomAD rs1879926816, CADD 21.20
- A60P (p.Ala60Pro), ESP rs142569954, ExAC rs142569954, TOPMed rs142569954, gnomAD rs142569954, Uncertain significance
- A60S (p.Ala60Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, CADD 3.02, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- A60T (p.Ala60Thr), rs142569954, ClinGen CA7012386, ClinVar RCV001958120, ESP rs142569954, CADD 7.86, PolyPhen-2 0.01, Uncertain significance, not provided
- S61I (p.Ser61Ile), cosmic curated COSV57527
- S61N (p.Ser61Asn), cosmic curated COSV10463
- S61T (p.Ser61Thr), Ensembl rs1879926324, CADD 18.50
- A63E (p.Ala63Glu), TOPMed rs1879925584, CADD 8.14, PolyPhen-2 0.00
- R64G (p.Arg64Gly), ESP rs139147111, ExAC rs139147111, TOPMed rs139147111, gnomAD rs139147111, CADD 4.26, PolyPhen-2 0.00
- R64L (p.Arg64Leu), rs201002254, ClinGen CA7012381, ClinVar RCV001112194, ClinVar RCV002556190, CADD 3.80, PolyPhen-2 0.00, Uncertain significance, not provided; Hirschsprung disease, susceptibility to, 2
- R64P (p.Arg64Pro), ExAC rs201002254, TOPMed rs201002254, gnomAD rs201002254, CADD 4.89, PolyPhen-2 0.00, Uncertain significance, not provided
- R64W (p.Arg64Trp), rs139147111, cosmic curated COSV57529, ESP rs139147111, ExAC rs139147111, CADD 8.00, PolyPhen-2 0.00, Uncertain significance, not provided
- S65* (p.Ser65Ter), rs2501609661, ClinGen CA388452849, ClinVar RCV003692799, Pathogenic
- S65L (p.Ser65Leu), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, Variant assessed as somatic; moderate impact.
- S65P (p.Ser65Pro), rs2501609675, ClinGen CA388452852, ClinVar RCV003695655, CADD 22.10, PolyPhen-2 0.00, Uncertain significance, not provided
- S65T (p.Ser65Thr), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10052, Variant assessed as somatic; moderate impact.
- L66W (p.Leu66Trp), Ensembl rs2137639919, CADD 17.70, PolyPhen-2 0.28
- P68L (p.Pro68Leu), rs201737510, ClinGen CA253049867, ClinVar RCV000606747, TOPMed rs201737510, AlphaMissense 0.08, MetaLR 0.22, Uncertain significance, not specified
- P68R (p.Pro68Arg), rs201737510, ClinGen CA388452829, ClinVar RCV004384566, AlphaMissense 0.08, MetaLR 0.22, Uncertain significance, Inborn genetic diseases
- A69T (p.Ala69Thr), NCI-TCGA Cosmic COSV5751, cosmic curated COSV57518, Variant assessed as somatic; moderate impact.
- A69V (p.Ala69Val), rs1019947807, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57521, TOPMed rs1019947807, CADD 23.10, PolyPhen-2 0.02, Variant assessed as somatic; moderate impact.
- E70D (p.Glu70Asp), cosmic curated COSV10052
- E70K (p.Glu70Lys), rs748181676, ExAC rs748181676, gnomAD rs748181676, CADD 11.90, PolyPhen-2 0.00, Uncertain significance, Inborn genetic diseases
- V71L (p.Val71Leu), rs2137639877, ClinGen CA388452815, ClinVar RCV001942796, Ensembl rs2137639877, CADD 0.98, PolyPhen-2 0.00, Uncertain significance, not provided
- P72L (p.Pro72Leu), cosmic curated COSV57520
- P72S (p.Pro72Ser), rs150750272, ClinGen CA7012377, ClinVar RCV002619703, ClinVar RCV006460458, CADD 14.80, PolyPhen-2 0.05, Uncertain significance, not specified; not provided
- K73E (p.Lys73Glu), 1000Genomes rs201488838, CADD 9.09, PolyPhen-2 0.02
- G74E (p.Gly74Glu), cosmic curated COSV57520, Ensembl rs2137639853
- G74R (p.Gly74Arg), TOPMed rs1879923046, gnomAD rs1879923046, CADD 13.80, PolyPhen-2 0.11, Uncertain significance, Inborn genetic diseases
- G74V (p.Gly74Val), cosmic curated COSV57524
- D75N (p.Asp75Asn), rs1230438816, gnomAD rs1230438816, AlphaMissense 0.08, MetaLR 0.12, Variant assessed as somatic; moderate impact.
- R76G (p.Arg76Gly), ExAC rs201207916, TOPMed rs201207916, gnomAD rs201207916, CADD 17.20, PolyPhen-2 0.00, Likely benign
- R76M (p.Arg76Met), rs2228271, ClinGen CA7012375, ClinVar RCV001568259, UniProt VAR 024255, CADD 16.50, PolyPhen-2 0.27, Conflicting interpretations, not provided
- R76W (p.Arg76Trp), ExAC rs201207916, TOPMed rs201207916, gnomAD rs201207916, Likely benign
- T77M (p.Thr77Met), rs1227502849, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57527, TOPMed rs1227502849, CADD 12.10, PolyPhen-2 0.01, Variant assessed as somatic; moderate impact.
- T77R (p.Thr77Arg), TOPMed rs1227502849, gnomAD rs1227502849, CADD 6.21, PolyPhen-2 0.00
- G79A (p.Gly79Ala), TOPMed rs1280900661, gnomAD rs1280900661, CADD 16.00, PolyPhen-2 0.01
- G79E (p.Gly79Glu), TOPMed rs1280900661, gnomAD rs1280900661, CADD 16.80, PolyPhen-2 0.01
- S80F (p.Ser80Phe), gnomAD rs1403988440, CADD 9.13, PolyPhen-2 0.04
- S80P (p.Ser80Pro), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57520, CADD 1.09, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- P81L (p.Pro81Leu), rs756427784, ClinGen CA7012373, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57524, CADD 14.40, PolyPhen-2 0.00, Uncertain significance, not provided
- P82A (p.Pro82Ala), Ensembl rs1879920399
- P82S (p.Pro82Ser), cosmic curated COSV57520
- R83C (p.Arg83Cys), rs771230818, ClinGen CA7012371, ClinVar RCV003032765, ClinVar RCV003054329, CADD 25.20, PolyPhen-2 0.59, Uncertain significance, not provided; Inborn genetic diseases
- R83H (p.Arg83His), NCI-TCGA Cosmic COSV5751, cosmic curated COSV57518, Ensembl rs1879919961, AlphaMissense 0.09, MetaLR 0.09, Variant assessed as somatic; moderate impact.
- R83L (p.Arg83Leu), rs1879919961, ClinGen CA388452741, ClinVar RCV003722335, AlphaMissense 0.09, MetaLR 0.09, Uncertain significance, not provided
- T84I (p.Thr84Ile), ExAC rs752412963, gnomAD rs752412963, CADD 10.30, PolyPhen-2 0.04
- T84N (p.Thr84Asn), ExAC rs752412963, gnomAD rs752412963, CADD 7.13, PolyPhen-2 0.00
- I85V (p.Ile85Val), rs1879919327, ClinGen CA388452733, ClinVar RCV001890612, TOPMed rs1879919327, AlphaMissense 0.06, MetaLR 0.04, Uncertain significance, not provided
- S86F (p.Ser86Phe), cosmic curated COSV57520, Ensembl rs1879919153, CADD 22.40, PolyPhen-2 0.00
- P87H (p.Pro87His), gnomAD rs1425908419, CADD 23.10, PolyPhen-2 0.18
- P87S (p.Pro87Ser), ExAC rs759133540, gnomAD rs759133540, CADD 22.80, PolyPhen-2 0.61
- P87T (p.Pro87Thr), ExAC rs759133540, gnomAD rs759133540
- P88A (p.Pro88Ala), gnomAD rs1410175049
- P88L (p.Pro88Leu), ExAC rs200756568, TOPMed rs200756568, gnomAD rs200756568, CADD 25.40, PolyPhen-2 0.46
- P89L (p.Pro89Leu), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57524, CADD 18.10, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- P89R (p.Pro89Arg), gnomAD rs1028136288, CADD 16.90, PolyPhen-2 0.01
- P89S (p.Pro89Ser), TOPMed rs1879917906, CADD 19.80, PolyPhen-2 0.01
- C90F (p.Cys90Phe), Ensembl rs1566316870
- C90Y (p.Cys90Tyr), NCI-TCGA Cosmic COSV5752, cosmic curated COSV57527, Variant assessed as somatic; moderate impact.
- Q91E (p.Gln91Glu), rs2137639673, ClinGen CA388452697, ClinVar RCV001770725, Ensembl rs2137639673, AlphaMissense 0.06, MetaLR 0.03, Uncertain significance, not provided
- Q91H (p.Gln91His), cosmic curated COSV10439
- G92E (p.Gly92Glu), ESP rs148189360, ExAC rs148189360, TOPMed rs148189360, gnomAD rs148189360, CADD 11.50
- P93H (p.Pro93His), cosmic curated COSV10816
- I94M (p.Ile94Met), rs748380116, ClinGen CA388452674, ClinVar RCV003668707, CADD 7.38, PolyPhen-2 0.43, Uncertain significance, not provided
- I94S (p.Ile94Ser), TOPMed rs1235006032, gnomAD rs1235006032, CADD 15.10, PolyPhen-2 0.00
- I94V (p.Ile94Val), ExAC rs772055405, TOPMed rs772055405, gnomAD rs772055405, CADD 15.80, PolyPhen-2 0.00
- E95K (p.Glu95Lys), cosmic curated COSV57523
- E95Q (p.Glu95Gln), rs1282405488, NCI-TCGA Cosmic COSV5752, cosmic curated COSV57526, AlphaMissense 0.12, MetaLR 0.10, Variant assessed as somatic; moderate impact.
- E95V (p.Glu95Val), ExAC rs774676772, gnomAD rs774676772, CADD 25.10, PolyPhen-2 0.07
- K97E (p.Lys97Glu), gnomAD rs1280780830, CADD 23.50, PolyPhen-2 0.00
- K97N (p.Lys97Asn), cosmic curated COSV57523
- E98* (p.Glu98Ter), rs2501608750, ClinGen CA388452649, ClinVar RCV003989082, Pathogenic
- E98G (p.Glu98Gly), cosmic curated COSV57521
- T99I (p.Thr99Ile), Ensembl rs201575712, CADD 23.00, PolyPhen-2 0.06
- T99P (p.Thr99Pro), ExAC rs768598369, gnomAD rs768598369, Uncertain significance, not provided
- Y102* (p.Tyr102Ter), rs1064797178, ClinGen CA388452617, ClinVar RCV000657773, gnomAD rs1064797178, Pathogenic
- Y102C (p.Tyr102Cys), rs2501608613, ClinGen CA388452618, ClinVar RCV003566016, CADD 32.00, PolyPhen-2 1.00, Uncertain significance, not provided
- Y102H (p.Tyr102His), TOPMed rs1879915974
- I103V (p.Ile103Val), TOPMed rs894919134, gnomAD rs894919134, CADD 22.60, PolyPhen-2 0.13, Uncertain significance, Inborn genetic diseases
- N104I (p.Asn104Ile), ExAC rs780355308, TOPMed rs780355308, gnomAD rs780355308, CADD 23.70, PolyPhen-2 0.96
- N104S (p.Asn104Ser), ExAC rs780355308, TOPMed rs780355308, gnomAD rs780355308, CADD 24.10, PolyPhen-2 0.53
- T105M (p.Thr105Met), rs368400131, ClinGen CA7012356, cosmic curated COSV57519, ClinVar RCV002028484, CADD 29.40, PolyPhen-2 0.97, Uncertain significance, Inborn genetic diseases; not provided
- S108P (p.Ser108Pro), cosmic curated COSV57525
- L110F (p.Leu110Phe), cosmic curated COSV57519
- L110V (p.Leu110Val), TOPMed rs1180581930, gnomAD rs1180581930, CADD 20.30
- V111E (p.Val111Glu), gnomAD rs1467139505, CADD 31.00, PolyPhen-2 0.96
Public EDNRB analysis runs
- EDNRB analysis run — EDNRB (857 variants) — completed 2026-08-27